SAR tools have long been the purview of small molecule medicinal chemists. As Biologics and sequence-based therapeutics become more pervasive, a new set of Sequence-Activity-Relationship tools are gaining importance in drug discovery. This webcast will showcase how AbbVie has been working with PerkinElmer solutions that extend their SAR analysis capabilities to include both small molecules and biologics in a single extensible platform that promises to expedite the lead discovery process.

Featured Speakers

Virginia Saulnier

Data Scientist
AbbVie

Virginia Saulnier is a data scientist at AbbVie, a global, research-based biopharmaceutical company committed to developing innovative therapies for some of the world's most complex and critical conditions. As a member of the R&D Information Research team, Virginia supports the data science needs of R&D scientists, with a primary focus on data analytics and visualization in the biologics and bioinformatics space. Virginia joined AbbVie after graduating from Loyola University Chicago, where she earned her MS in Software Engineering and BS in Biology and Bioinformatics.

David Gosalvez, Ph.D.

Executive Director of Science and Technology
PerkinElmer

David Gosalvez, Ph.D., is Executive Director of Science and Technology at PerkinElmer, Inc., where he leads an interdisciplinary team of domain experts in software and database architecture. His team is chartered with creating novel scientific data management solutions. Dr. Gosalvez received his undergraduate degree from UC Berkley and his Ph.D. in chemistry from Massachusetts Institute of Technology.

Date:  Wednesday, April 22, 2020
Time:  11am ET / 8am PT
Duration:  1 Hour

Register now for this webinar